Todd Nemet
YOU?
Author Swipe
View article: Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial Open
Background To date, no medication has slowed the progression of Parkinson’s disease (PD). Preclinical, epidemiological, and experimental data on humans all support many benefits of endurance exercise among persons with PD. The key question…